We are live on ! Find out more
ONC

BeOne Medicines Ltd

199 hedge funds and large institutions have $6.8B invested in BeOne Medicines Ltd in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 56 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

25% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 56

4% more funds holding

Funds holding: 192199 (+7)

2% more capital invested

Capital invested by funds: $6.65B → $6.8B (+$146M)

0.15% more ownership

Funds ownership: 6.18%6.33% (+0.15%)

17% less call options, than puts

Call options by funds: $9.84M | Put options by funds: $11.8M

36% less funds holding in top 10

Funds holding in top 10: 149 (-5)

Holders
199
Holders Change
+7
Holders Change %
+3.65%
% of All Funds
4.31%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.19%
New
32
Increased
70
Reduced
56
Closed
25
Calls
$9.84M
Puts
$11.8M
Net Calls
-$1.99M
Net Calls Change
-$31.6M
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$1.58B
Fidelity Investments
2
Fidelity Investments
Massachusetts
$740M +$1.72M +12,765 +0.2%
Capital International Investors
3
Capital International Investors
California
$593M +$110M +818,425 +80%
HA
4
HHLR Advisors
Cayman Islands
$586M
Wellington Management Group
5
Wellington Management Group
Massachusetts
$349M -$16.7M -123,567 -4%
Temasek Holdings
6
Temasek Holdings
Singapore
$300M
BlackRock
7
BlackRock
New York
$254M +$6.28M +46,540 +2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$164M +$5.83M +43,244 +4%
Canada Pension Plan Investment Board
9
Canada Pension Plan Investment Board
Ontario, Canada
$153M +$4.99M +37,008 +3%
HIM
10
Hillhouse Investment Management
Cayman Islands
$137M
Primecap Management
11
Primecap Management
California
$121M -$148K -1,100 -0.1%
BC
12
Boxer Capital
California
$119M
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$106M -$19.9M -147,359 -16%
CGT
14
Capital Guardian Trust
California
$93.8M +$50.5M +374,286 +110%
State Street
15
State Street
Massachusetts
$93.5M +$13.8M +102,603 +17%
AG
16
Artal Group
Luxembourg
$79.2M
Northern Trust
17
Northern Trust
Illinois
$74.8M -$10.5K -78 -0%
O
18
OppenheimerFunds
New York
$72.7M -$3.11M -23,024 -4%
Janus Henderson Group
19
Janus Henderson Group
United Kingdom
$62.4M -$997K -7,389 -2%
Norges Bank
20
Norges Bank
Norway
$53.7M +$8.92M +66,122 +19%
Russell Investments Group
21
Russell Investments Group
United Kingdom
$52.5M +$15.4M +113,796 +40%
AllianceBernstein
22
AllianceBernstein
Tennessee
$51.3M +$1.52M +11,267 +3%
Ameriprise
23
Ameriprise
Minnesota
$47.2M -$2.2M -16,330 -4%
Goldman Sachs
24
Goldman Sachs
New York
$42.7M +$5.9M +43,712 +16%
CII
25
Capital International Inc
California
$41.3M +$15.8M +117,318 +60%

ONC Hedge Fund Activity: Q1 2019 in Review

199 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2019, worth a combined $6.8B — up 2.2% from $6.65B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ONC positions and 25 closed out — a net gain of 7 holders — while 70 added to existing stakes and 56 trimmed.

The largest buyer was Capital International Investors, adding an estimated $110M. The largest seller was Myriad Asset Management, exiting entirely with an estimated $23.3M sold.

  • 199 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2019, up from 192 in Q4 2018.
  • Funds reported $6.8B of BeOne Medicines Ltd stock for Q1 2019, up 2.2% quarter-over-quarter.
  • 32 funds opened new BeOne Medicines Ltd positions in Q1 2019 and 25 closed out, a net change of +7 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2019 was Capital International Investors, an estimated $110M added.
  • The largest BeOne Medicines Ltd seller in Q1 2019 was Myriad Asset Management, an estimated $23.3M sold.

Based on aggregated 13F filings for Q1 2019.